CBAY

Cymabay Therapeutics

Delisted

CBAY was delisted on the 21st of March, 2024.

17 hedge funds and large institutions have $33.9M invested in Cymabay Therapeutics in 2014 Q3 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
17
Holders Change
+17
Holders Change %
% of All Funds
0.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
LOAMU
1
Lombard Odier Asset Management (USA)
New York
$8.55M 1,250,000 +1,250,000 New
Jennison Associates
2
Jennison Associates
New York
$6.84M 1,000,000 +1,000,000 New
SAM
3
Sectoral Asset Management
Quebec, Canada
$4.85M 708,585 +708,585 New
DM
4
Deerfield Management
New York
$3.51M 513,206 +513,206 New
SFM
5
Sphera Funds Management
Israel
$3.35M 490,355 +490,355 New
RSCM
6
Rock Springs Capital Management
Maryland
$2.05M 300,000 +300,000 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$1.93M 282,447 +282,447 New
AllianceBernstein
8
AllianceBernstein
Tennessee
$1.61M 234,974 +234,974 New
IHM
9
Iguana Healthcare Management
New York
$855K 125,000 +125,000 New
EEG
10
E.E. Geduld
$171K 25,000 +25,000 New
ACI
11
Alpha Cubed Investments
California
$137K 20,000 +20,000 New
Barclays
12
Barclays
United Kingdom
$14K 2,400 +2,400 New
ClearBridge Investments
13
ClearBridge Investments
New York
$12K 1,760 +1,760 New
CWAM
14
Columbia Wanger Asset Management
Illinois
$2K 228 +228 New
SM
15
Sabby Management
Florida
$1.71K 249,900 +249,900 New
Morgan Stanley
16
Morgan Stanley
New York
$0 25 +25 New
Citigroup
17
Citigroup
New York
$0 43 +43 New